scholarly article | Q13442814 |
P356 | DOI | 10.1038/S41379-019-0365-Y |
P698 | PubMed publication ID | 31527708 |
P50 | author | Roberto N. Miranda | Q37842538 |
Francisco Vega | Q40001462 | ||
P2093 | author name string | L Jeffrey Medeiros | |
P2860 | cites work | Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8) | Q24650427 |
Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a rare clinicopathologic entity with poor prognosis | Q27851477 | ||
Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma | Q28242984 | ||
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas | Q28299069 | ||
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease | Q29619158 | ||
KSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiation | Q30433391 | ||
Identification of antigenic proteins encoded by human herpesvirus 8 and seroprevalence in the general population and among patients with and without Kaposi's sarcoma | Q33801927 | ||
HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma | Q33889296 | ||
Bone marrow failure associated with human herpesvirus 8 infection after transplantation | Q33924650 | ||
Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. | Q33939333 | ||
An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease | Q34157797 | ||
Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease | Q34431511 | ||
Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease | Q34636851 | ||
Molecular Biology of Kaposi's Sarcoma-associated Herpesvirus and Related Oncogenesis | Q35124404 | ||
Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival | Q36368882 | ||
Kaposi's sarcoma and its associated herpesvirus | Q36487309 | ||
Competence and competition: the challenge of becoming a long-lived plasma cell | Q36594883 | ||
Circulating plasmablasts/plasma cells: a potential biomarker for IgG4-related disease | Q37635260 | ||
Long-lived autoreactive plasma cells drive persistent autoimmune inflammation | Q37833902 | ||
Extracavitary KSHV-associated large B-Cell lymphoma: a distinct entity or a subtype of primary effusion lymphoma? Study of 9 cases and review of an additional 43 cases | Q38025946 | ||
KSHV-associated and EBV-associated Germinotropic Lymphoproliferative Disorder: New Findings and Review of the Literature | Q39156336 | ||
HHV8/KSHV-Positive Lymphoproliferative Disorders and the Spectrum of Plasmablastic and Plasma Cell Neoplasms: 2015 SH/EAHP Workshop Report-Part 3. | Q39232108 | ||
How I treat HHV8/KSHV-related diseases in posttransplant patients. | Q39554617 | ||
KSHV/HHV-8 infection of human hematopoietic progenitor (CD34+) cells: persistence of infection during hematopoiesis in vitro and in vivo | Q40303480 | ||
HHV8-related lymphoid proliferations: a broad spectrum of lesions from reactive lymphoid hyperplasia to overt lymphoma | Q40373195 | ||
HHV-8+, EBV+ multicentric plasmablastic microlymphoma in an HIV+ Man: the spectrum of HHV-8+ lymphoproliferative disorders expands | Q40441055 | ||
Fatal HHV-8-associated hemophagocytic syndrome in an HIV-negative immunocompetent patient with plasmablastic variant of multicentric Castleman disease (plasmablastic microlymphoma). | Q40492010 | ||
Primary human herpesvirus 8 infection in immunocompetent children | Q40587020 | ||
Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiation | Q40660780 | ||
Human interleukin-6 is in vivo an autocrine growth factor for human herpesvirus-8-infected malignant B lymphocytes | Q40913931 | ||
Fatal Outcome of Multiple Clinical Presentations of Human Herpesvirus 8-related Disease After Solid Organ Transplantation | Q41134958 | ||
Diverse clinicopathologic features in human herpesvirus 8-associated lymphomas lead to diagnostic problems | Q41666536 | ||
PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies | Q41826795 | ||
Human herpesvirus 8 infection in patients with POEMS syndrome-associated multicentric Castleman's disease | Q42602227 | ||
Primary human herpesvirus 8 infection generates a broadly specific CD8(+) T-cell response to viral lytic cycle proteins. | Q42646886 | ||
Expression of p53 and human herpesvirus-8 (HHV-8)-encoded latency-associated nuclear antigen with inhibition of apoptosis in HHV-8-associated malignancies | Q42665921 | ||
KSHV/HHV-8 associated lymph node based lymphomas in HIV seronegative subjects. Report of two cases with anaplastic large cell morphology and plasmablastic immunophenotype. | Q43010178 | ||
A case of successful management of HHV-8⁺, EBV⁺ germinotropic lymphoproliferative disorder (GLD). | Q43632604 | ||
Molecular profile of Epstein-Barr virus infection in HHV-8-positive primary effusion lymphoma | Q43813156 | ||
KSHV- and EBV-associated germinotropic lymphoproliferative disorder. | Q44182960 | ||
Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: a single-institution study. | Q44633978 | ||
KSHV/HHV8-associated lymphoma simulating anaplastic large cell lymphoma | Q44857155 | ||
KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma | Q44987723 | ||
Role of vascular endothelial growth factor/vascular permeability factor in the pathogenesis of Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphomas | Q45000519 | ||
Gene expression analysis of plasmablastic lymphoma identifies downregulation of B-cell receptor signaling and additional unique transcriptional programs | Q45012890 | ||
Plasmablastic lymphoma among human immunodeficiency virus-positive patients: results of a single center's experience. | Q45347202 | ||
Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasm | Q45421951 | ||
Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8. | Q45761402 | ||
Primary effusion lymphoma in women: report of two cases of Kaposi's sarcoma herpes virus-associated effusion-based lymphoma in human immunodeficiency virus-negative women. | Q45767233 | ||
Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. | Q45769785 | ||
Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus | Q45846355 | ||
PD-L1 and Notch1 expression in KSHV/HHV-8 and EBV associated germinotropic lymphoproliferative disorder: case report and review of the literature | Q46108279 | ||
The full spectrum of Castleman disease: 273 patients studied over 20 years | Q47578601 | ||
Lymphoproliferative disorders with concurrent HHV8 and EBV infection: beyond primary effusion lymphoma and germinotropic lymphoproliferative disorder. | Q47590029 | ||
Cytokeratin-positive primary effusion lymphoma: a diagnostic challenge | Q48113285 | ||
Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts. | Q52008432 | ||
KSHV induces immunoglobulin rearrangements in mature B lymphocytes. | Q52586065 | ||
Extracavitary/solid variant of primary effusion lymphoma | Q57114623 | ||
Monoclonality or Oligoclonality of Human Herpesvirus 8 Terminal Repeat Sequences in Kaposi's Sarcoma and Other Diseases | Q57952920 | ||
Rituximab therapy for HIV-associated Castleman disease | Q58004108 | ||
Lymph Nodes Involved by Multicentric Castleman Disease Among HIV-positive Individuals are Often Involved by Kaposi Sarcoma | Q59621846 | ||
Viral, immunologic, and clinical features of primary effusion lymphoma | Q64101661 | ||
A systemic lymphoproliferative disorder with morphologic features of Castleman's disease. Pathological findings in 15 patients. | Q64936532 | ||
Immunoblastic Lymphoma in Persons with AIDS-Associated Kaposi’s Sarcoma: a Role for Kaposi’s Sarcoma–Associated Herpesvirus | Q73397236 | ||
Human herpesvirus 8-associated primary effusion lymphoma in HIV--patients: a clinicopidemiologic variant resembling classic Kaposi's sarcoma | Q77900236 | ||
Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma arising in the subarachnoid space | Q78143942 | ||
Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV+ multicentric Castleman disease (MCD) | Q79786222 | ||
Plasmablastic microlymphoma occurring in human herpesvirus 8 (HHV-8)-positive multicentric Castleman's disease and featuring a follicular growth pattern | Q80575788 | ||
P433 | issue | 1 | |
P304 | page(s) | 18-28 | |
P577 | publication date | 2019-09-16 | |
P1433 | published in | Modern Pathology | Q15724578 |
P1476 | title | KSHV/HHV8-positive large B-cell lymphomas and associated diseases: a heterogeneous group of lymphoproliferative processes with significant clinicopathological overlap | |
P478 | volume | 33 |
Q99563206 | [Primary effusion lymphoma in a HIV-negative patient: case report and literatures review] | cites work | P2860 |
Search more.